Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

1.87
+0.02001.08%
Post-market: 1.870.00000.00%19:43 EDT
Volume:35.97K
Turnover:66.85K
Market Cap:10.23M
PE:-0.08
High:1.91
Open:1.80
Low:1.80
Close:1.85
Loading ...
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Oct 09, 2024

Major Issues Report

Form 8-K - Current report
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 20, 2024

Major Issues Report

Form 8-K - Current report
Sep 19, 2024

Major Issues Report

Form 8-K - Current report
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Sep 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report